Gillard, Michel <br/><br/>
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.  [electronic resource] 

 -  European journal of pharmacology  Apr 2006 
 - 102-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2006.02.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Azides--metabolism<br/>Binding Sites<br/>Binding, Competitive<br/>Brain--metabolism<br/>CHO Cells<br/>Cerebellum--metabolism<br/>Cerebral Cortex--metabolism<br/>Cricetinae<br/>Cricetulus<br/>Female<br/>Gene Expression<br/>Hippocampus--metabolism<br/>Humans<br/>Kinetics<br/>Levetiracetam<br/>Male<br/>Membrane Glycoproteins--genetics<br/>Nerve Tissue Proteins--genetics<br/>Piracetam--analogs & derivatives<br/>Pyrrolidines--metabolism<br/>Recombinant Proteins--metabolism<br/>Tritium